Barr Seeks To Capitalize On Pliva Infrastructure, Faces Obstacles To Benefits
Executive Summary
Barr is moving ahead with its integration of Pliva, but the firm must overcome several obstacles before it can capitalize on its recently acquired European infrastructure
You may also be interested in...
Barr Cuts Low-Volume Products In Post-Merger Rationalization
Barr is paring low-volume products from its portfolio and pipeline following the integration of Pliva's products and R&D programs
Barr Cuts Low-Volume Products In Post-Merger Rationalization
Barr is paring low-volume products from its portfolio and pipeline following the integration of Pliva's products and R&D programs
Generic Drug Service, Not Pricing, Is Key Performance Factor – Lehman’s Silver
The success of generic companies will be determined more by the breadth and quality of their offerings than product pricing, Lehman Brothers Senior VP-Specialty Pharmaceutical Research Rich Silver told the Generic Pharmaceutical Association